Why PZOO May Move to New Lows

Today, Pazoo, Inc. (PZOO) filed another preliminary proxy in advance of a dramatic boost to its authorized shares. The company is raising its common share authorization by almost 2 billion to 2.95 billion from 0.98 billion. It is also increasing its preferred stock authorization from 20mm to 50mm. Investors should be aware that some of these securities are convertible.

The dilution so far in 2015 has been extraordinary, as the company had 193mm shares at year-end, up from 101mm at the end of 2013, but now reports over 660mm as of 6/22. Part of the reason for the boost in the authorized shares is to cover shares reserved for potential issuance to holders of convertible notes. The preliminary proxy lists seven different entities that have loaned the company $799K, requiring a reserve of over 600mm shares. These loans are all due in less than a year and cost 8-12% in interest costs.

In addition to extensive liquidity challenges that could lead to further share issuance if the company doesn't generate enough cash to pay its debt, the float faces a bigger near-term challenge. Since its inception as a public company, PZOO has been relying upon financing provided by James Farinella of Integrated Capital Partners, Inc. (ICPI). Farinella provides money to the company in exchange for convertible preferred stock (Series A). At the end of the first quarter, the company had 1.478526mm shares outstanding, up from 1.203526mm at year-end. The terms of conversion are 100 shares to 1, so this represented a potential addition of almost 148mm common shares.

The company reported $435K of conversions (into 43.5mm shares) after the end of the quarter. It also issued another 1.4375mm Preferred A for just $225K. THIS IS A RED FLAG, as the price is just $0.00157 per share on a converted ...

Read More
Comments

Slides from Houlihan's Valuation of Kannaway for MJNA

5 weeks ago, MJNA announced that it was buying Kannaway, the MLM that distributes some of its products. The press release, which didn't detail the terms of the transaction, alluded to a valuation analysis performed by Houlihan Capital that suggested ...

Read More
Comments

A Good Time to Grab Some GW Pharma

UK-based GW Pharma (GWPH) is allowing long-term investors a good entry today following the release of Q1 results and a conference call that followed.  The stock continued to retrace a good portion of its massive rally in early January today but ...

Read More
Comments

MJNA: It's What They Didn't Say About Kannaway That Should Make You Run Away

In typical fashion for the company, Medical Marijuana, Inc. (MJNA) dropped an aggressive press release lacking substance in what appears to be a last-ditch effort to interest investors in its comatose stock.  Before the market opened on 1/22/15, the company ...

Read More
Comments

Red Ahead for this Black Eye of the Green Rush

In a move that has been signaled by a brewing battle, Medbox (MDBX) founder and controlling shareholder Vincent Mehdizadeh moved today to replace the entire Board of Directors.  In a definitive proxy filed with the SEC, Mehdizadeh named himself, employees Matthew ...

Read More
Comments

Pot Stocks Pay Off: A Review of the Cannabis Sector

NOTE:  This is satire

What a year it was for the marijuana sector, bouncing back from a challenging 2014. While the sector ended the year well below the 2014 highs despite more than tripling in price, investors are optimistic that ...

Read More
Comments

420 Investor Interview: Paul Rosen, CEO of PharmaCan Capital

One of the most exciting themes for those looking to capitalize on the changing global cannabis industry is the rollout of Canada's Marihuana for Medical Purposes Regulations (MMPR). Health Canada, which oversees Canada’s national medical marijuana program, has issued licenses ...

Read More
Comments

Election Survey 11/03/14 - Public Survey

420 Investor conducted a survey for the public that was exactly the same as its internal survey.  The public survey, which was posted on Twitter and Facebook, consisted of six questions and was open for 50 hours, closing at 9 A.M. EDT on 11/03, ...

Read More
Comments

Stay Informed with the 420 Investor Newsletter

After a year of helping investors navigate the "Wild West" of the cannabis stock sector as 420 Investor has evolved into the leading collaborative due diligence platform, we are pleased to offer the 420 Investor Newsletter.

This monthly effort is ...

Read More
Comments

GrowBLOX "Blows" It

GrowBLOX Sciences (GBLX) posted a press release this morning. This company has spent an enormous amount of money on p.r. and investor relations and has pushed the envelope (using GoogleAds, for instance, to promote its ticker). Shockingly, the company misspelled its ...

Read More
Comments

420 Investor Interview: Tom Bollich, CEO of Surna

Surna (SRNA), based in Boulder, CO, addresses one of the key challenges facing the cannabis cultivation industry: Energy consumption. The company, which began operations this year, has technology that it has acquired that will help growers reduce one of the ...

Read More
Comments

Guest Post - Desmond Fargo: "Cen Biotech: A Promise Delivered"

The author of this article, Desmond Fargo, gave me permission to publish this piece on Creative Edge Nutrition (FITX)

The purpose of this article is to provide useful insight into Cen Biotech's recent press release regarding license, and also provide ...

Read More
Comments